What is SVCC's issuance of warrants to purchase common stock?

SVCC (SVCC) reported issuance of warrants to purchase common stock of $1.22M in Q1 2025.

What does issuance of warrants to purchase common stock mean?

The accounting adjustment made to additional paid-in capital to reflect the issuance of warrants to purchase common stock. This represents the equity component of derivative instruments issued to investors or service providers. It is used to evaluate the impact of equity-linked compensation or financing on the company's capital structure.

SVCC SVCC Issuance of warrants to purchase common stock

Issuance of warrants to purchase common stock at other companies

Ispire Technology Inc.ISPR

$91.49K—

Envoy MedicalCOCH

$882K+348%

CO2 Energy Transition Corp. Common StockNOEM

$51.75K—

Oruka Therapeutics, Inc.ORKA

$2.52M-75.7%

ADMA BiologicsADMA

$1.4M—

Evommune EVMN

$150—

Other financials

Income statement

See full

Operating income-$183.2K+10.4%

Net income$1.2M+22.4%

Balance sheet

See full

Cash & equivalents$181.4K-70.7%

Total equity-$5.1M-12.5%

Total assets$158.4M+3.6%

Cash flow

See full

Operating cash flow-$172.7K+44.9%

Valuation

See full

Market cap$228.04M+3.5%

P/E41.3×—

Returns & leverage

See full

Return on equity-114.6%—

Current ratio2.2×-3.2×

Where this comes from

Reported directly by SVCC in its filing.

Tagged under the XBRL concept us-gaap:AdjustmentsToAdditionalPaidInCapitalWarrantIssued.

The official record: SVCC’s 10-Q, filed May 14, 2026, on SEC EDGAR. View the filing →

Ask your AI about SVCC's issuance of warrants to purchase common stock.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is SVCC's issuance of warrants to purchase common stock?: SVCC (SVCC) reported issuance of warrants to purchase common stock of $1.22M in Q1 2025.
What does issuance of warrants to purchase common stock mean?: The accounting adjustment made to additional paid-in capital to reflect the issuance of warrants to purchase common stock. This represents the equity component of derivative instruments issued to investors or service providers. It is used to evaluate the impact of equity-linked compensation or financing on the company's capital structure.